Together withthe biological results obtained in this study, the dosimetry confirms that161Tb may be better suited than177Lu for sterilizing small cell clusters in advancedmetastatic prostate cancer with radiolabeled PSMA ligands. The gene discussed is FOLH1; the disease is prostate cancer.